人工人工植牙市场：依植入类型、材质、应用、最终用途及通路划分－2026-2032年全球预测

预计到 2025 年，人工人工植牙市场价值将达到 50.6 亿美元，到 2026 年将成长至 55 亿美元，到 2032 年将达到 90.5 亿美元，复合年增长率为 8.64%。

关键市场统计数据
基准年 2025	50.6亿美元
预计年份：2026年	55亿美元
预测年份 2032	90.5亿美元
复合年增长率 (%)	8.64%

生物材料的进步、临床创新和治疗过程的演变正在共同塑造人工人工植牙的策略和应用。

人工植牙种植领域融合了生物材料科学、外科创新和不断发展的治疗流程。临床医生和製造商致力于提供能够改善骨整合、减少植入併发症并缩短復原时间的修復方案。同时，患者期望的改变和人口结构的变化也推动了对美观效果和可预测的长期性能的需求，引发了植入设计、表面处理和修復介面方面的一系列改进。

材料创新、数位化临床工作流程和采购行为的改变如何共同重塑人工植牙领域的竞争定位和临床路径

在科技、临床实践和购买行为的共同推动下，植牙领域正经历着一场变革性的转变。植入形状和表面工程的创新优化了骨整合特性，从而实现了微创手术通讯协定，并扩大了即时负重适应症。如今，数位化工作流程将影像、虚拟规划和电脑辅助製造相结合，降低了手术操作的差异性，并支援个人化的修復方案，以满足患者对速度和美观的需求。

评估美国2025年实施的关税植入供应链和采购选择重塑所带来的营运、采购和定价影响

美国将于2025年实施的新关税政策，为植入供应链的各个环节带来了特定的压力，改变了植入製造商和下游临床医生的成本结构和筹资策略。进口金属、高纯度钛原料以及专用机械加工和积层製造零件的关税，推高了依赖全球供应商的企业的到岸成本。这迫使一些製造商重新审视供应商合同，实现采购多元化，并探索本地生产和近岸外包等替代方案，以降低进口关税风险。

深度分割分析将植入设计、生物材料、临床适应症、临床环境和通路与战略产品和商业性选择联繫起来。

分析的细分揭示了产品创新和商业性重点在植入类型、材料成分、临床应用、终端用户环境和分销方式的交汇点。植入类型特征包括：骨内植体（涵盖刀片形和根形）、骨膜下植体、穿骨植体以及专为严重上颚骨吸收病例设计的颧骨植入。每种设计方案都有其独特的手术流程和修復介面，这决定了临床医生的培训要求，并为具有特定解剖和功能需求的患者群体提供差异化的价值提案。

美洲、欧洲、中东和非洲以及亚太地区的区域法规结构、生产能力和临床应用模式将如何决定战略优先顺序和市场准入？

区域趋势——美洲、欧洲、中东和非洲以及亚太地区——导致不同的需求驱动因素、法规结构和供应链现状，这些因素共同影响创新应用和商业策略。在美洲，强大的医疗服务网络以及私人牙科诊所和专科中心的高手术量推动了临床应用。同时，报销政策的细微差别和支付方的参与度影响高附加价值产品的推广速度。与北美製造商和服务供应商的供应链合作支持了近岸外包，尤其是在贸易政策调整优先考虑关键零件国内生产之后。

以整合的临床生态系统、实证医学和通路多元化为核心的企业策略，旨在实现竞争优势并提升合作伙伴忠诚度。

主要企业植入公司之间的竞争体现了对整合解决方案、临床证据产生和通路多元化的重视。许多公司正在寻求差异化的产品系列，将创新的植体植入形状、专有的表面处理技术和基于平台的修復组件相结合，以建立临床一致的生态系统。製造商、数位化牙科服务提供者和学术机构之间的策略联盟加速了新概念的检验，并透过培训计画和同行评审的出版物支持临床应用。

整合产品创新、供应链韧性和以临床医生为中心的商业化等实用策略，以确保可持续的竞争优势。

产业领导者应采取多维策略，将产品创新与稳健的供应链和以临床医生为中心的商业化相结合。优先发展模组化平台，在限制产品种类和製造复杂性的同时，实现表面处理和假体介面的渐进式创新。同时，投资临床证据项目，检验短期手术效果和中期功能结果，以增强临床医师的信心并促进与支付者的沟通。利用真实世界资料收集与对照临床试验并行进行，加速证据累积。

调查方法的透明度：详细说明如何透过专家访谈、文献综述和检验，得出检验的临床和商业性见解，以支持策略决策。

我们的研究途径结合了定性和定量方法，以确保获得可靠且可操作的洞见。主要研究包括对植入医生、医疗机构和医院的采购负责人、医疗设备製造商的研发负责人以及分销合作伙伴进行结构化访谈，以收集有关临床偏好、采购驱动因素和营运限制的第一手资讯。专家小组和咨询会议检验了新出现的主题，并完善了临床优先事项的解释。次要研究整合了同行评审文献、监管指导文件、临床试验註册信息和上市公司披露信息，以支持主要研究结果并为技术趋势提供背景信息。

临床、营运和商业性需求的整合将决定哪些机构能够将创新转化为持续应用和长期的临床信心。

人工植牙产业正处于策略转折点，材料创新、数位化临床工作流程和不断变化的供应链现状正在交汇融合，共同塑造未来的竞争力。临床医生越来越重视能够提供可预测的生物整合和卓越修復效果的系统，而製造商则必须平衡监管审查、关税成本压力以及提供强有力的临床证据等多重需求。这些融合的动态有利于那些能够将强大的研发开发平臺、灵活的生产基地和整合服务相结合，从而支持临床医生培训和病例规划的企业。

目录

第一章：序言

第二章调查方法

• 研究设计
• 研究框架
• 市场规模预测
• 数据三角测量
• 调查结果
• 调查前提
• 调查限制

第三章执行摘要

• 首席主管观点
• 市场规模和成长趋势
• 2025年市占率分析
• FPNV定位矩阵，2025
• 新的商机
• 下一代经营模式
• 产业蓝图

第四章 市场概览

• 产业生态系与价值链分析
• 波特五力分析
• PESTEL 分析
• 市场展望
• 上市策略

第五章 市场洞察

• 消费者洞察与终端用户观点
• 消费者体验基准
• 机会地图
• 分销通路分析
• 价格趋势分析
• 规制コンプライアンスと标准フレームワーク
• ESG与永续性分析
• 中断和风险情景
• 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依植入类型分類的人工人工植牙市场

• 骨内
  • 刀片类型
  • 根类型
• 骨膜下植入
• 经骨法
• 颧骨植入

9. 按材料分類的人工人工植牙市场

• 钛
  • 纯钛
  • 钛合金
• 氧化锆
  • 3Y-TZP
  • 氧化铝增韧氧化锆

第十章 按应用分類的人工人工植牙市场

• 全弓修復
  • 四人组队
  • 桿件持有类型
  • 覆盖式义齿
• 多颗牙齿修復体
  • 桥
  • 局部义齿
• 单颗牙齿替换

第十一章 依最终用途分類的人工人工植牙市场

• 诊所
• 医院
• 专业牙科中心

第十二章 人工人工植牙市场（依通路划分）

• 直销
• 经销商
• 在线的

第十三章 各地区人工人工植牙市场

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十四章 人工人工植牙市场（依类别划分）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十五章 各国人工人工植牙市场

• 我们
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十六章：美国人工人工植牙市场

第十七章：中国的人工人工植牙市场

第十八章 竞争格局

• 市场集中度分析，2025年
  • 浓度比（CR）
  • 赫芬达尔-赫希曼指数 (HHI)
• 近期趋势及影响分析，2025 年
• 2025年产品系列分析
• 基准分析，2025 年
• BioHorizons IPH, Inc.
• Danaher Corporation
• DENTSPLY SIRONA Inc.
• DIO IMPLANT
• Envista Holdings Corporation
• Hiossen, Inc.
• MegaGen Implant Co., Ltd.
• MIS Implants Technologies Ltd.
• Osstem Implant Co., Ltd.
• Straumann Holding AG
• Zimmer Biomet Holdings, Inc.

The Artificial Dental Implant Market was valued at USD 5.06 billion in 2025 and is projected to grow to USD 5.50 billion in 2026, with a CAGR of 8.64%, reaching USD 9.05 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 5.06 billion
Estimated Year [2026]	USD 5.50 billion
Forecast Year [2032]	USD 9.05 billion
CAGR (%)	8.64%

Contextualizing the convergence of biomaterials advances, clinical innovation, and care pathway evolution shaping artificial dental implant strategy and adoption

The artificial dental implant landscape sits at the intersection of biomaterials science, surgical innovation, and evolving care pathways. Clinicians and manufacturers increasingly focus on delivering restorative solutions that improve osseointegration, reduce peri-implant complications, and shorten rehabilitation timelines. Concurrently, patient expectations and demographic shifts drive demand for aesthetic outcomes and predictable long-term performance, prompting a wave of refinement across implant designs, surface treatments, and prosthetic interfaces.

Technological advances such as digital planning and guided surgery, additive manufacturing for customized abutments, and new material blends have expanded clinical options while introducing new operational considerations for implant providers. Payment models and reimbursement environments influence adoption patterns and procurement strategies across clinics, hospitals, and specialty dental centers. As a result, stakeholders must balance clinical efficacy with supply chain resilience and regulatory compliance to maintain competitiveness in a rapidly evolving therapeutic area.

This introduction frames the discussion by spotlighting the core engineering drivers, clinical priorities, and commercial forces shaping implant development and delivery. It also establishes the basis for deeper analysis of segmentation, regional dynamics, and strategic responses that follow, ensuring readers can trace how innovation, policy, and distribution interact to influence choices made by clinicians, purchasers, and device manufacturers.

How materials innovation, digital clinical workflows, and shifting procurement behaviors are jointly redefining competitive positioning and clinical pathways in dental implantology

The sector is undergoing transformative shifts driven by converging forces across technology, clinical practice, and buyer behavior. Innovations in implant geometry and surface engineering have refined osseointegration profiles, which in turn enable less invasive surgical protocols and expanded indications for immediate loading. Digital workflows now link imaging, virtual planning, and computer-aided manufacturing, reducing procedural variability and supporting personalized restorative solutions that align with patient expectations for speed and aesthetics.

At the same time, materials science is progressing beyond traditional metal-only constructs to include high-strength ceramics that address aesthetic demands and biocompatibility concerns. These material shifts create new product differentiation opportunities while requiring manufacturers to validate long-term clinical performance through targeted research and post-market surveillance. Distribution and purchasing models are also evolving; clinics and specialty centers increasingly evaluate direct procurement options and online channels alongside traditional distributor relationships, reshaping commercial go-to-market strategies.

Regulatory scrutiny and payer engagement are influencing product development priorities, compelling companies to integrate health economics and real-world evidence into clinical dossiers. Collectively, these shifts demand that manufacturers and clinicians adopt agile development cycles, invest in clinical data generation, and cultivate integrated digital and service offerings to maintain relevance as clinical practices and patient expectations continue to evolve.

Assessing the operational, sourcing, and pricing consequences of United States tariff measures introduced in 2025 that reshape implant supply chains and procurement choices

The introduction of new tariff measures in the United States in 2025 has introduced tangible pressure points along the implant supply chain, altering cost structures and sourcing strategies for implant manufacturers and downstream clinicians. Tariffs on imported metals, high-purity titanium feedstock, and specialized machining or additive manufacturing components increase landed costs for companies reliant on global suppliers. This has driven several manufacturers to reassess supplier contracts, diversify inputs, and explore localized production or nearshoring alternatives to mitigate exposure to import levies.

Clinics and specialty centers now face amplified procurement complexity as device pricing adjustments are evaluated against clinical benefit and reimbursement realities. In response, some larger manufacturers have initiated cost optimization programs focused on material utilization efficiency, consolidation of component suppliers, and redesigns that maintain clinical performance while simplifying assembly. At the same time, tariffs have encouraged investment in domestic supply capabilities for critical materials and manufacturing services, shortening lead times and enhancing control over quality pathways but also necessitating capital deployment and certification timelines.

Regulatory compliance and customs administration have become more salient considerations, adding administrative overhead and extending time-to-delivery for certain products. These developments underscore an operational imperative: organizations must align commercial contracts, inventory strategies, and R&D prioritization with a trade environment that rewards supply chain resilience, validated domestic production, and flexible distribution models capable of responding to policy-driven cost shifts.

Deep segmentation insights connecting implant designs, biomaterials, clinical indications, care settings, and distribution routes to strategic product and commercial choices

Analytical segmentation illuminates where product innovation and commercial focus intersect across implant type, material composition, clinical application, end user setting, and distribution approaches. Implant type distinctions include endosteal designs, which encompass both blade form and root form variants, as well as subperiosteal constructs, transosteal solutions, and zygomatic implants tailored for severe maxillary resorption. Each design pathway presents unique surgical workflows and prosthetic interfaces, informing clinician training requirements and offering differentiated value propositions for patient groups with specific anatomic or functional needs.

Material segmentation separates titanium and zirconia families. Titanium pathways include pure titanium and titanium alloy options that deliver well-documented osseointegration profiles and mechanical resilience, while zirconia divides into high-translucency 3Y-TZP and alumina-toughened zirconia subtypes that pursue superior aesthetics and alternative biocompatibility attributes. Application-driven segmentation identifies full arch rehabilitation, multi-tooth replacement, and single-tooth replacement use cases. Full arch strategies further differentiate between all-on-four configurations, bar-retained prostheses, and overdenture solutions, whereas multi-tooth replacement covers bridge and partial denture restorations, each demanding distinct prosthetic planning and load management.

End-use segmentation captures clinical venues where implants are placed and managed, spanning clinics, hospital settings, and specialty dental centers, each with different purchase patterns, procedural volumes, and clinical support infrastructures. Finally, distribution channel differences between direct sales, distributor networks, and online procurement influence margin structures, service expectations, and go-to-market investment choices. Taken together, these segmentation lenses enable focused product development, targeted clinician training, and tailored commercial strategies that reflect the clinical, material, and channel-specific dynamics of the implant landscape.

How regional regulatory frameworks, manufacturing capabilities, and clinical adoption patterns in the Americas, EMEA, and Asia-Pacific determine strategic prioritization and market entry

Regional dynamics present differentiated demand drivers, regulatory frameworks, and supply chain realities across the Americas, Europe, Middle East & Africa, and Asia-Pacific, which collectively shape innovation adoption and commercial strategy. In the Americas, clinical adoption benefits from strong practitioner networks and high procedural volumes in private dental practices and specialist centers, with reimbursement nuances and payer engagement influencing the cadence of premium product uptake. Supply chain linkages with North American manufacturers and service providers support nearshoring initiatives, particularly in the wake of trade policy adjustments that prioritize domestic production for critical components.

In the Europe, Middle East & Africa region, regulatory harmonization efforts and diverse national reimbursement regimes create a mosaic of market entry requirements and pricing sensitivities. Clinical preferences in certain European markets favor aesthetic solutions, encouraging adoption of ceramic-based implants, while emerging healthcare investments in parts of the Middle East and Africa emphasize capacity building and specialist center development. Distribution in this region often relies on established distributor networks and localized clinical education programs to build surgeon familiarity and confidence with new systems.

Asia-Pacific features a mixture of advanced innovation hubs and rapidly expanding clinical volumes driven by demographic trends and rising patient affordability. Several countries in the region have developed strong manufacturing capabilities for implant components and prosthetic parts, enhancing export competitiveness and enabling integration with global supply chains. Across all regions, regulatory oversight, clinician training ecosystems, and distribution infrastructure remain critical determinants of how new implant technologies are introduced and scaled within local clinical practice.

Company strategies centered on integrated clinical ecosystems, evidence generation, and channel diversification that drive competitive differentiation and partner loyalty

Competitive dynamics among leading companies in the implant sector reflect an emphasis on integrated solutions, clinical evidence generation, and channel diversification. Many firms pursue differentiated product portfolios that combine innovative implant geometries, proprietary surface treatments, and platform-based restorative components to create clinically coherent ecosystems. Strategic partnerships between manufacturers, digital dentistry providers, and academic centers accelerate the validation of new concepts and support clinical adoption through training programs and peer-reviewed publications.

Investment in R&D and clinical trials remains a primary means of establishing credibility, while targeted acquisitions and equity partnerships enable rapid extension into complementary technologies such as digital planning software, guided surgery kits, and custom abutment manufacturing. Commercial models are evolving; some companies expand direct sales forces to enhance clinical engagement, while others leverage regional distributors and online channels to broaden reach and improve logistical efficiency. Service-level differentiation, including comprehensive clinician education, case planning support, and warranty frameworks, increasingly factors into purchasing decisions.

Sustainability of supply chains, transparency around material sourcing, and the ability to provide robust post-market data have become competitive advantages. Firms that can demonstrate consistent quality control, scalable manufacturing, and rapid technical support build stronger clinician loyalty and reduce barriers to switching. Taken together, these strategies underscore a competitive environment where clinical performance, system interoperability, and end-to-end service offerings are decisive in shaping partner and purchaser preferences.

Practical strategic moves for manufacturers and providers to align product innovation, supply resilience, and clinician-centric commercialization for sustained competitive advantage

Industry leaders should adopt a multi-dimensional strategy that links product innovation with resilient supply chains and clinician-centered commercialization. Prioritize modular platform development that allows incremental innovation in surface treatments and prosthetic interfaces while limiting SKU proliferation and manufacturing complexity. Simultaneously, invest in clinical evidence programs that validate both short-term surgical performance and medium-term functional outcomes to support clinician confidence and payer conversations, using real-world data collection alongside controlled clinical studies to accelerate evidence accumulation.

To mitigate trade-related volatility and policy risk, develop a supplier diversification roadmap that evaluates nearshoring, dual-sourcing, and strategic inventory buffers for critical materials like high-purity titanium and ceramic feedstock. Enhance service propositions by integrating digital planning tools, guided-surgery workflows, and remote case support to reduce procedural variability and improve clinical throughput. Expand channel strategies by balancing direct engagement for high-volume accounts with distributor partnerships and selective online offerings that improve accessibility for smaller practices.

Finally, strengthen post-market surveillance and feedback loops to inform iterative product improvements and to satisfy tightening regulatory expectations. Align commercial incentives and training programs with long-term patient outcome goals rather than transactional sales metrics, thereby fostering deeper clinical relationships and facilitating higher-value, sustained adoption of advanced implant systems.

Methodological transparency detailing how expert interviews, literature synthesis, and triangulation produced validated clinical and commercial insights for strategic decision-making

The research approach combined qualitative and quantitative methods to ensure robust, actionable insights. Primary research included structured interviews with implant surgeons, procurement managers from clinics and hospitals, R&D leaders at device firms, and distribution partners to capture first-hand perspectives on clinical preferences, procurement drivers, and operational constraints. Expert panels and advisory sessions validated emergent themes and refined the interpretation of clinical priorities. Secondary research synthesized peer-reviewed literature, regulatory guidance documents, clinical trial registries, and publicly available corporate disclosures to corroborate primary findings and to contextualize technology trajectories.

Data triangulation involved cross-referencing interview evidence with product literature, device registries, and manufacturing disclosures to identify consistent patterns and to detect outliers. The methodology emphasized transparency around data provenance, noting where insights derive from clinician experience, regulatory documentation, or company reporting. Limitations included variation in national regulatory frameworks that complicate direct comparisons and the proprietary nature of some clinical performance data, which constrains visibility into long-term outcomes for newer materials and designs.

To ensure replicability, the research outlined inclusion criteria for expert interviews, the timeframe for literature review, and the validation steps used to reconcile conflicting inputs. Overall, this mixed-methods approach prioritized clinical relevance, operational feasibility, and strategic applicability, delivering findings that support evidence-based decision-making across product development, regulatory planning, and commercial execution.

Synthesis of clinical, operational, and commercial imperatives that determine which organizations will convert innovation into durable adoption and long-term clinical trust

The artificial dental implant sector stands at a strategic inflection point where materials innovation, digital clinical workflows, and evolving supply chain realities collectively shape future competitive dynamics. Clinicians increasingly value systems that deliver predictable biological integration and superior prosthetic outcomes, while manufacturers must reconcile the demands of regulatory scrutiny, tariff-driven cost pressures, and the need for compelling clinical evidence. These converging forces favor organizations that can combine robust R&D pipelines with flexible manufacturing footprints and integrated service offerings that support clinician training and case planning.

Across segments and regions, the decisive differentiators will be the ability to demonstrate reproducible clinical performance, to provide efficient digital and logistical support, and to maintain resilient sourcing strategies in the face of policy volatility. Companies that align product roadmaps with validated clinical outcomes, invest in domestic or diversified manufacturing where appropriate, and adapt distribution models to meet the needs of clinics, hospitals, and specialty centers will be best positioned to translate innovation into sustained clinical and commercial adoption.

Ultimately, the pathway to growth hinges on executing an evidence-driven commercialization plan that balances technological ambition with pragmatic operational strategies, ensuring that new implant solutions deliver clear clinical value while remaining accessible and reliable for providers and patients alike.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Artificial Dental Implant Market, by Implant Type

• 8.1. Endosteal
  • 8.1.1. Blade Form
  • 8.1.2. Root Form
• 8.2. Subperiosteal
• 8.3. Transosteal
• 8.4. Zygomatic

9. Artificial Dental Implant Market, by Material

• 9.1. Titanium
  • 9.1.1. Pure Titanium
  • 9.1.2. Titanium Alloy
• 9.2. Zirconia
  • 9.2.1. 3Y-TZP
  • 9.2.2. Alumina Toughened Zirconia

10. Artificial Dental Implant Market, by Application

• 10.1. Full Arch Rehabilitation
  • 10.1.1. All On Four
  • 10.1.2. Bar Retained
  • 10.1.3. Overdenture
• 10.2. Multi Tooth Replacement
  • 10.2.1. Bridge
  • 10.2.2. Partial Denture
• 10.3. Single Tooth Replacement

11. Artificial Dental Implant Market, by End Use

• 11.1. Clinic
• 11.2. Hospital
• 11.3. Specialty Dental Center

12. Artificial Dental Implant Market, by Distribution Channel

• 12.1. Direct Sales
• 12.2. Distributors
• 12.3. Online

13. Artificial Dental Implant Market, by Region

• 13.1. Americas
  • 13.1.1. North America
  • 13.1.2. Latin America
• 13.2. Europe, Middle East & Africa
  • 13.2.1. Europe
  • 13.2.2. Middle East
  • 13.2.3. Africa
• 13.3. Asia-Pacific

14. Artificial Dental Implant Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Artificial Dental Implant Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. United States Artificial Dental Implant Market

17. China Artificial Dental Implant Market

18. Competitive Landscape

• 18.1. Market Concentration Analysis, 2025
  • 18.1.1. Concentration Ratio (CR)
  • 18.1.2. Herfindahl Hirschman Index (HHI)
• 18.2. Recent Developments & Impact Analysis, 2025
• 18.3. Product Portfolio Analysis, 2025
• 18.4. Benchmarking Analysis, 2025
• 18.5. BioHorizons IPH, Inc.
• 18.6. Danaher Corporation
• 18.7. DENTSPLY SIRONA Inc.
• 18.8. DIO IMPLANT
• 18.9. Envista Holdings Corporation
• 18.10. Hiossen, Inc.
• 18.11. MegaGen Implant Co., Ltd.
• 18.12. MIS Implants Technologies Ltd.
• 18.13. Osstem Implant Co., Ltd.
• 18.14. Straumann Holding AG
• 18.15. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

• FIGURE 1. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SHARE, BY KEY PLAYER, 2025
• FIGURE 3. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET, FPNV POSITIONING MATRIX, 2025
• FIGURE 4. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY IMPLANT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 5. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 7. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 9. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 11. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 12. UNITED STATES ARTIFICIAL DENTAL IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 13. CHINA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

• TABLE 1. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 2. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
• TABLE 3. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ENDOSTEAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 4. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ENDOSTEAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 5. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ENDOSTEAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 6. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ENDOSTEAL, 2018-2032 (USD MILLION)
• TABLE 7. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY BLADE FORM, BY REGION, 2018-2032 (USD MILLION)
• TABLE 8. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY BLADE FORM, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 9. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY BLADE FORM, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 10. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ROOT FORM, BY REGION, 2018-2032 (USD MILLION)
• TABLE 11. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ROOT FORM, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 12. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ROOT FORM, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 13. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY SUBPERIOSTEAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 14. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY SUBPERIOSTEAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 15. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY SUBPERIOSTEAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 16. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TRANSOSTEAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 17. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TRANSOSTEAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 18. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TRANSOSTEAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 19. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ZYGOMATIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 20. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ZYGOMATIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 21. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ZYGOMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 22. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 23. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
• TABLE 24. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 25. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 26. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TITANIUM, 2018-2032 (USD MILLION)
• TABLE 27. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY PURE TITANIUM, BY REGION, 2018-2032 (USD MILLION)
• TABLE 28. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY PURE TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 29. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY PURE TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 30. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TITANIUM ALLOY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 31. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TITANIUM ALLOY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 32. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TITANIUM ALLOY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 33. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ZIRCONIA, BY REGION, 2018-2032 (USD MILLION)
• TABLE 34. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ZIRCONIA, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 35. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ZIRCONIA, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 36. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
• TABLE 37. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY 3Y-TZP, BY REGION, 2018-2032 (USD MILLION)
• TABLE 38. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY 3Y-TZP, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 39. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY 3Y-TZP, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 40. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ALUMINA TOUGHENED ZIRCONIA, BY REGION, 2018-2032 (USD MILLION)
• TABLE 41. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ALUMINA TOUGHENED ZIRCONIA, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 42. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ALUMINA TOUGHENED ZIRCONIA, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 43. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 44. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY FULL ARCH REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 45. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY FULL ARCH REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 46. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY FULL ARCH REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 47. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY FULL ARCH REHABILITATION, 2018-2032 (USD MILLION)
• TABLE 48. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ALL ON FOUR, BY REGION, 2018-2032 (USD MILLION)
• TABLE 49. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ALL ON FOUR, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 50. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ALL ON FOUR, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 51. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY BAR RETAINED, BY REGION, 2018-2032 (USD MILLION)
• TABLE 52. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY BAR RETAINED, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 53. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY BAR RETAINED, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 54. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY OVERDENTURE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 55. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY OVERDENTURE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 56. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY OVERDENTURE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 57. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MULTI TOOTH REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
• TABLE 58. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MULTI TOOTH REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 59. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MULTI TOOTH REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 60. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MULTI TOOTH REPLACEMENT, 2018-2032 (USD MILLION)
• TABLE 61. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY BRIDGE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 62. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY BRIDGE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 63. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY BRIDGE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 64. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY PARTIAL DENTURE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 65. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY PARTIAL DENTURE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 66. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY PARTIAL DENTURE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 67. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY SINGLE TOOTH REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
• TABLE 68. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY SINGLE TOOTH REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 69. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY SINGLE TOOTH REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 70. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 71. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 72. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 73. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 74. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 75. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 76. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 77. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY SPECIALTY DENTAL CENTER, BY REGION, 2018-2032 (USD MILLION)
• TABLE 78. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY SPECIALTY DENTAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 79. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY SPECIALTY DENTAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 80. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 81. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 82. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 83. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 84. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 85. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 86. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 87. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 88. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 89. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 90. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 91. AMERICAS ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 92. AMERICAS ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
• TABLE 93. AMERICAS ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ENDOSTEAL, 2018-2032 (USD MILLION)
• TABLE 94. AMERICAS ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 95. AMERICAS ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TITANIUM, 2018-2032 (USD MILLION)
• TABLE 96. AMERICAS ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
• TABLE 97. AMERICAS ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 98. AMERICAS ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY FULL ARCH REHABILITATION, 2018-2032 (USD MILLION)
• TABLE 99. AMERICAS ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MULTI TOOTH REPLACEMENT, 2018-2032 (USD MILLION)
• TABLE 100. AMERICAS ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 101. AMERICAS ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 102. NORTH AMERICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 103. NORTH AMERICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
• TABLE 104. NORTH AMERICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ENDOSTEAL, 2018-2032 (USD MILLION)
• TABLE 105. NORTH AMERICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 106. NORTH AMERICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TITANIUM, 2018-2032 (USD MILLION)
• TABLE 107. NORTH AMERICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
• TABLE 108. NORTH AMERICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 109. NORTH AMERICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY FULL ARCH REHABILITATION, 2018-2032 (USD MILLION)
• TABLE 110. NORTH AMERICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MULTI TOOTH REPLACEMENT, 2018-2032 (USD MILLION)
• TABLE 111. NORTH AMERICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 112. NORTH AMERICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 113. LATIN AMERICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 114. LATIN AMERICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
• TABLE 115. LATIN AMERICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ENDOSTEAL, 2018-2032 (USD MILLION)
• TABLE 116. LATIN AMERICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 117. LATIN AMERICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TITANIUM, 2018-2032 (USD MILLION)
• TABLE 118. LATIN AMERICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
• TABLE 119. LATIN AMERICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 120. LATIN AMERICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY FULL ARCH REHABILITATION, 2018-2032 (USD MILLION)
• TABLE 121. LATIN AMERICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MULTI TOOTH REPLACEMENT, 2018-2032 (USD MILLION)
• TABLE 122. LATIN AMERICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 123. LATIN AMERICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ENDOSTEAL, 2018-2032 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TITANIUM, 2018-2032 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY FULL ARCH REHABILITATION, 2018-2032 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MULTI TOOTH REPLACEMENT, 2018-2032 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 135. EUROPE ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 136. EUROPE ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
• TABLE 137. EUROPE ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ENDOSTEAL, 2018-2032 (USD MILLION)
• TABLE 138. EUROPE ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 139. EUROPE ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TITANIUM, 2018-2032 (USD MILLION)
• TABLE 140. EUROPE ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
• TABLE 141. EUROPE ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 142. EUROPE ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY FULL ARCH REHABILITATION, 2018-2032 (USD MILLION)
• TABLE 143. EUROPE ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MULTI TOOTH REPLACEMENT, 2018-2032 (USD MILLION)
• TABLE 144. EUROPE ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 145. EUROPE ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 146. MIDDLE EAST ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 147. MIDDLE EAST ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
• TABLE 148. MIDDLE EAST ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ENDOSTEAL, 2018-2032 (USD MILLION)
• TABLE 149. MIDDLE EAST ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 150. MIDDLE EAST ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TITANIUM, 2018-2032 (USD MILLION)
• TABLE 151. MIDDLE EAST ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
• TABLE 152. MIDDLE EAST ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 153. MIDDLE EAST ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY FULL ARCH REHABILITATION, 2018-2032 (USD MILLION)
• TABLE 154. MIDDLE EAST ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MULTI TOOTH REPLACEMENT, 2018-2032 (USD MILLION)
• TABLE 155. MIDDLE EAST ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 156. MIDDLE EAST ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 157. AFRICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 158. AFRICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
• TABLE 159. AFRICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ENDOSTEAL, 2018-2032 (USD MILLION)
• TABLE 160. AFRICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 161. AFRICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TITANIUM, 2018-2032 (USD MILLION)
• TABLE 162. AFRICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
• TABLE 163. AFRICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 164. AFRICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY FULL ARCH REHABILITATION, 2018-2032 (USD MILLION)
• TABLE 165. AFRICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MULTI TOOTH REPLACEMENT, 2018-2032 (USD MILLION)
• TABLE 166. AFRICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 167. AFRICA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 168. ASIA-PACIFIC ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 169. ASIA-PACIFIC ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
• TABLE 170. ASIA-PACIFIC ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ENDOSTEAL, 2018-2032 (USD MILLION)
• TABLE 171. ASIA-PACIFIC ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 172. ASIA-PACIFIC ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TITANIUM, 2018-2032 (USD MILLION)
• TABLE 173. ASIA-PACIFIC ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
• TABLE 174. ASIA-PACIFIC ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 175. ASIA-PACIFIC ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY FULL ARCH REHABILITATION, 2018-2032 (USD MILLION)
• TABLE 176. ASIA-PACIFIC ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MULTI TOOTH REPLACEMENT, 2018-2032 (USD MILLION)
• TABLE 177. ASIA-PACIFIC ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 178. ASIA-PACIFIC ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 179. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 180. ASEAN ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 181. ASEAN ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
• TABLE 182. ASEAN ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ENDOSTEAL, 2018-2032 (USD MILLION)
• TABLE 183. ASEAN ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 184. ASEAN ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TITANIUM, 2018-2032 (USD MILLION)
• TABLE 185. ASEAN ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
• TABLE 186. ASEAN ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 187. ASEAN ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY FULL ARCH REHABILITATION, 2018-2032 (USD MILLION)
• TABLE 188. ASEAN ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MULTI TOOTH REPLACEMENT, 2018-2032 (USD MILLION)
• TABLE 189. ASEAN ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 190. ASEAN ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 191. GCC ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 192. GCC ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
• TABLE 193. GCC ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ENDOSTEAL, 2018-2032 (USD MILLION)
• TABLE 194. GCC ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 195. GCC ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TITANIUM, 2018-2032 (USD MILLION)
• TABLE 196. GCC ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
• TABLE 197. GCC ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 198. GCC ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY FULL ARCH REHABILITATION, 2018-2032 (USD MILLION)
• TABLE 199. GCC ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MULTI TOOTH REPLACEMENT, 2018-2032 (USD MILLION)
• TABLE 200. GCC ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 201. GCC ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 202. EUROPEAN UNION ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 203. EUROPEAN UNION ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
• TABLE 204. EUROPEAN UNION ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ENDOSTEAL, 2018-2032 (USD MILLION)
• TABLE 205. EUROPEAN UNION ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 206. EUROPEAN UNION ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TITANIUM, 2018-2032 (USD MILLION)
• TABLE 207. EUROPEAN UNION ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
• TABLE 208. EUROPEAN UNION ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 209. EUROPEAN UNION ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY FULL ARCH REHABILITATION, 2018-2032 (USD MILLION)
• TABLE 210. EUROPEAN UNION ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MULTI TOOTH REPLACEMENT, 2018-2032 (USD MILLION)
• TABLE 211. EUROPEAN UNION ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 212. EUROPEAN UNION ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 213. BRICS ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 214. BRICS ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
• TABLE 215. BRICS ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ENDOSTEAL, 2018-2032 (USD MILLION)
• TABLE 216. BRICS ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 217. BRICS ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TITANIUM, 2018-2032 (USD MILLION)
• TABLE 218. BRICS ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
• TABLE 219. BRICS ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 220. BRICS ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY FULL ARCH REHABILITATION, 2018-2032 (USD MILLION)
• TABLE 221. BRICS ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MULTI TOOTH REPLACEMENT, 2018-2032 (USD MILLION)
• TABLE 222. BRICS ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 223. BRICS ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 224. G7 ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 225. G7 ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
• TABLE 226. G7 ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ENDOSTEAL, 2018-2032 (USD MILLION)
• TABLE 227. G7 ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 228. G7 ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TITANIUM, 2018-2032 (USD MILLION)
• TABLE 229. G7 ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
• TABLE 230. G7 ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 231. G7 ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY FULL ARCH REHABILITATION, 2018-2032 (USD MILLION)
• TABLE 232. G7 ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MULTI TOOTH REPLACEMENT, 2018-2032 (USD MILLION)
• TABLE 233. G7 ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 234. G7 ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 235. NATO ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 236. NATO ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
• TABLE 237. NATO ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ENDOSTEAL, 2018-2032 (USD MILLION)
• TABLE 238. NATO ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 239. NATO ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TITANIUM, 2018-2032 (USD MILLION)
• TABLE 240. NATO ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
• TABLE 241. NATO ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 242. NATO ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY FULL ARCH REHABILITATION, 2018-2032 (USD MILLION)
• TABLE 243. NATO ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MULTI TOOTH REPLACEMENT, 2018-2032 (USD MILLION)
• TABLE 244. NATO ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 245. NATO ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 246. GLOBAL ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 247. UNITED STATES ARTIFICIAL DENTAL IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 248. UNITED STATES ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
• TABLE 249. UNITED STATES ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ENDOSTEAL, 2018-2032 (USD MILLION)
• TABLE 250. UNITED STATES ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 251. UNITED STATES ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TITANIUM, 2018-2032 (USD MILLION)
• TABLE 252. UNITED STATES ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
• TABLE 253. UNITED STATES ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 254. UNITED STATES ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY FULL ARCH REHABILITATION, 2018-2032 (USD MILLION)
• TABLE 255. UNITED STATES ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MULTI TOOTH REPLACEMENT, 2018-2032 (USD MILLION)
• TABLE 256. UNITED STATES ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 257. UNITED STATES ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 258. CHINA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 259. CHINA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
• TABLE 260. CHINA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ENDOSTEAL, 2018-2032 (USD MILLION)
• TABLE 261. CHINA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 262. CHINA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY TITANIUM, 2018-2032 (USD MILLION)
• TABLE 263. CHINA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
• TABLE 264. CHINA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 265. CHINA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY FULL ARCH REHABILITATION, 2018-2032 (USD MILLION)
• TABLE 266. CHINA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY MULTI TOOTH REPLACEMENT, 2018-2032 (USD MILLION)
• TABLE 267. CHINA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 268. CHINA ARTIFICIAL DENTAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)